Retatrutide: Triple GIP/GLP-1/Glucagon Agonist in Research

Retatrutide (research designation NVRX-RT3, also known in the literature as LY3437943) is a synthetic, single-molecule peptide that has become one of the most-studied compounds in metabolic-signaling research. Its defining feature is unusual: it acts as a triple agonist, engaging three different receptors — GLP-1, GIP, and glucagon — with a single molecule.

One molecule, three receptors

Most incretin-related research peptides target a single receptor. Retatrutide was engineered to bind and activate three at once:

• GLP-1 receptor — central to incretin signaling and glucose-dependent insulin research.
• GIP receptor — the second major incretin pathway, frequently studied alongside GLP-1 in metabolic models.
• Glucagon receptor — associated in research with hepatic glucose handling and energy expenditure.

Combining all three activities in one sequence makes retatrutide a uniquely efficient laboratory tool: instead of dosing three separate compounds, a research group can probe three interconnected pathways with one well-characterized peptide.

Why the triple-agonist design matters

The three receptors retatrutide targets sit at overlapping nodes of metabolic regulation. Studying them in isolation can miss the cross-talk between pathways. A single triple agonist lets researchers observe how simultaneous receptor engagement behaves in a controlled system — useful for receptor-pharmacology, signal-transduction, and structure-activity work. This is why retatrutide is often used as a reference compound when characterizing new incretin-class molecules.

Areas of research interest

• GLP-1, GIP, and glucagon receptor pharmacology and binding studies
• Incretin signaling and glucose-homeostasis models
• Energy-expenditure and metabolic-rate research
• Comparative studies against single- and dual-agonist peptides (e.g. tirzepatide)

These are areas of laboratory investigation only. Nothing here describes or implies any human, clinical, or therapeutic use.

Reference properties

• CAS: 2381089-83-2
• Molecular formula: C221H342N46O68
• Molecular weight: ~4731.4 g/mol
• Class: GLP-1 / GIP / glucagon triple receptor agonist
• Form: lyophilized powder, ≥99% purity (HPLC)

Handling, reconstitution & storage

Retatrutide ships as a lyophilized (freeze-dried) powder. Store the sealed vial at −20 °C for long-term stability. Reconstitute with bacteriostatic water; once in solution, keep refrigerated at 2–8 °C, protect from light, and avoid repeated freeze–thaw cycles, which degrade peptide integrity. For a deeper walkthrough, see our guide on reconstitution & storage.

Identity and purity: why the COA matters

A triple agonist is only as useful as its documented identity and purity. Every research lot should be accompanied by a Certificate of Analysis (COA) confirming identity by mass spectrometry and purity by HPLC. If you are not sure how to read one, our COA checklist breaks down what to look for — and Noverix Verify lets our scientists review a COA for you.